A study in pigs, which shows that inhaled vaccines could potentially reduce viral transmission and improve efficiency, is an important step toward advancing vaccines for human use.
Oxford Cancer, the Oxford Vaccine Group and the Pandemic Sciences Institute have announced a new collaboration with Belgian biotech innovator Univercells.
A brand-new season of The Oxford Colloquy \u2013 a podcast series of conversations with leading experts in science and healthcare \u2013 is launched this week by Oxford Vaccine Group.
Launch of UK trial is major milestone in developing a vaccine against Marburg virus \u2013 a highly virulent disease that is fatal in up to 88% of cases.
PSI scientists are launching a new computer simulations project to model vaccine clinical trial designs and strengthen global response to pandemic threats.
The exhibition, which features stories and items from University of Oxford researchers, explores the worldwide effort to develop vaccines against COVID-19 and shares the inspiring stories of scientists collaborating around the globe to save lives. Closing on 12 May, the exhibition has welcomed millions of visitors in London, India and China.
A randomised controlled trial to evaluate the efficacy and safety of treatments for bubonic plague has enrolled over 220 patients in Madagascar, marking a critical milestone in evidence generation for plague treatments.
Researchers from Oxford Vaccine Group and the Pandemic Sciences Institute welcomed a delegation of vaccine researchers from Belgium to further UK-Belgian collaboration on vaccine development and manufacture.
The University of Oxford this week welcomed the Rt Hon Andrew Mitchell MP, Minister for Development and Africa, to the laboratories and clinics of several of its vaccine development groups.
A partnership between CEPI, Barinthus Biotherapeutics and the University of Oxford aims to fast-track the development of a potential vaccine for the prevention of Middle East Respiratory Syndrome (MERS).
Scientific advisors to the International Pandemic Preparedness Secretariat (IPPS) visited the University of Oxford\u2019s vaccine laboratories as part of a two-day meeting of the global coalition.
CEPI will provide up to $25 million to the University of Oxford to complete early development of prototype vaccines against the Jun\u00edn virus, with a new project led by Professor Teresa Lambe.
The RECOVERY trial, the leading global clinical trial of treatments for COVID-19, has expanded to find effective treatments for patients hospitalised with flu.
Clinical researchers and representatives from the World Health Organization defined a bold new path for global research collaboration in acute care at a conference co-hosted by ISARIC, a global federation of investigator-led clinical research networks.
The University of Oxford has launched a new global vaccine collaboration, backed by \u00a38 million funding from UK Research and Innovation (UKRI), and led by two PSI Principal Investigators.
The UK trial is the next step in the development of a vaccine to protect people against MERS \u2013 a deadly viral illness with no current vaccines and the potential to cause a pandemic.
![\"\"](\"https://www.psi.ox.ac.uk/news-and-opinion/pig-research-paves-way-for-human-respiratory-vaccine-development/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n